2 research outputs found
Possibilities and immediate results of tracheo-bronchoplastic operations in lung cancer
Currently, surgical treatment of lung cancer is unthinkable without the use of tracheo-bronchoplastic operations, which in advanced specialized clinics take up to 5-10% of all radical operations. A retrospective study was conducted involving 21 patients with central lung cancer who underwent 22 tracheo-bronchoplastic radical surgeries over the period 2000-2021. Among the operated patients there were 18 men and 3 women aged from 42 to 67 years (average age 54.5 years + / - 12 years). Comorbid status was present in 20 patients. The morphological structure of the tumors was represented by carcinoid (2) and squamous cell carcinoma (19). The average duration of operations was 242.3 minutes (125-345 minutes), the average blood loss was 283.2 ml (50-1000 ml). Complications developed in 5 (22.7%) patients. Mortality was observed in 2 (9.1%) cases. The use of tracheo-bronchoplastic operations significantly expands the possibilities of thoracic surgery in the treatment of lung cancer, both due to the technical resectability of the tumor during the transition to the main bronchus and trachea, and due to the functional operability with low respiratory functions and the inability to perform pneumonectomyΠ Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΠΊΠ° Π»Π΅Π³ΠΊΠΎΠ³ΠΎ Π½Π΅ΠΌΡΡΠ»ΠΈΠΌΠΎ Π±Π΅Π· ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΡΠ°Ρ
Π΅ΠΎ-Π±ΡΠΎΠ½Ρ
ΠΎΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ, ΠΊΠΎΡΠΎΡΡΠ΅ Π² ΠΏΠ΅ΡΠ΅Π΄ΠΎΠ²ΡΡ
ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ°Ρ
Π·Π°Π½ΠΈΠΌΠ°ΡΡ Π΄ΠΎ 5-10% ΠΎΡ Π²ΡΠ΅Ρ
ΡΠ°Π΄ΠΈΠΊΠ°Π»ΡΠ½ΡΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ. ΠΡΠ»ΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΡΠ΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅, Π²ΠΊΠ»ΡΡΠ°ΡΡΠ΅Π΅ 21 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° Ρ ΡΠ΅Π½ΡΡΠ°Π»ΡΠ½ΡΠΌΠΈ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΡΠΌΠΈ ΡΠ°ΠΊΠ° Π»Π΅Π³ΠΊΠΎΠ³ΠΎ, ΠΊΠΎΡΠΎΡΡΠΌ Π±ΡΠ»ΠΈ Π²ΡΠΏΠΎΠ»Π½Π΅Π½Ρ 22 ΡΡΠ°Ρ
Π΅ΠΎ-Π±ΡΠΎΠ½Ρ
ΠΎΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ°Π΄ΠΈΠΊΠ°Π»ΡΠ½ΡΠ΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ Π·Π° ΠΏΠ΅ΡΠΈΠΎΠ΄ 2000-2021 Π³Π³. Π‘ΡΠ΅Π΄ΠΈ ΠΎΠΏΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π±ΡΠ»ΠΎ 18 ΠΌΡΠΆΡΠΈΠ½ ΠΈ 3 ΠΆΠ΅Π½ΡΠΈΠ½Ρ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 42 Π΄ΠΎ 67 Π»Π΅Ρ (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ β 54,5 Π³ΠΎΠ΄Π° +/- 12 Π»Π΅Ρ). ΠΠΎΠΌΠΎΡΠ±ΠΈΠ΄Π½ΡΠΉ ΡΡΠ°ΡΡΡ ΠΈΠΌΠ΅Π»ΡΡ Ρ 20 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΡΡΠΊΡΡΡΠ° ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ Π±ΡΠ»Π° ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Π° ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΈΠ΄ΠΎΠΌ (2) ΠΈ ΠΏΠ»ΠΎΡΠΊΠΎΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΌ ΡΠ°ΠΊΠΎΠΌ (19). Π‘ΡΠ΅Π΄Π½ΡΡ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 242,3 ΠΌΠΈΠ½. (125-345 ΠΌΠΈΠ½.), ΡΡΠ΅Π΄Π½ΡΡ ΠΊΡΠΎΠ²ΠΎΠΏΠΎΡΠ΅ΡΡ β 283,2 ΠΌΠ» (50-1000 ΠΌΠ»). ΠΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ ΡΠ°Π·Π²ΠΈΠ»ΠΈΡΡ Ρ 5 (22,7%) ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΠ΅ΡΠ°Π»ΡΠ½ΠΎΡΡΡ Π½Π°Π±Π»ΡΠ΄Π°Π»Π°ΡΡ Π² 2 (9,1%) ΡΠ»ΡΡΠ°ΡΡ
. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΡΠ°Ρ
Π΅ΠΎ-Π±ΡΠΎΠ½Ρ
ΠΎΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠ°ΡΡΠΈΡΡΠ΅Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ ΡΠΎΡΠ°ΠΊΠ°Π»ΡΠ½ΠΎΠΉ Ρ
ΠΈΡΡΡΠ³ΠΈΠΈ Π² Π»Π΅ΡΠ΅Π½ΠΈΠΈ ΡΠ°ΠΊΠ° Π»Π΅Π³ΠΊΠΎΠ³ΠΎ ΠΊΠ°ΠΊ Π·Π° ΡΡΠ΅Ρ ΡΠ΅Ρ
Π½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅Π·Π΅ΠΊΡΠ°Π±Π΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ ΠΏΡΠΈ ΠΏΠ΅ΡΠ΅Ρ
ΠΎΠ΄Π΅ Π½Π° Π³Π»Π°Π²Π½ΡΠΉ Π±ΡΠΎΠ½Ρ
ΠΈ ΡΡΠ°Ρ
Π΅Ρ, ΡΠ°ΠΊ ΠΈ Π·Π° ΡΡΠ΅Ρ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ ΠΎΠΏΠ΅ΡΠ°Π±Π΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΏΡΠΈ Π½ΠΈΠ·ΠΊΠΈΡ
ΡΡΠ½ΠΊΡΠΈΡΡ
Π΄ΡΡ
Π°Π½ΠΈΡ ΠΈ Π½Π΅Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΡΠΊΡΠΎΠΌΠΈ
Experience of tracheobronchoplastic surgery for lung cancer
Introduction. Currently, surgical treatment of lung cancer is impossible without the use of tracheobronchoplastic operations, which in advanced specialized clinics take up to 5-10% of all radical operationsΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΠΊΠ° Π»Π΅Π³ΠΊΠΎΠ³ΠΎ Π½Π΅Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ Π±Π΅Π· ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΡΠ°Ρ
Π΅ΠΎΠ±ΡΠΎΠ½Ρ
ΠΎΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ, ΠΊΠΎΡΠΎΡΡΠ΅ Π² ΠΏΠ΅ΡΠ΅Π΄ΠΎΠ²ΡΡ
ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ°Ρ
Π·Π°Π½ΠΈΠΌΠ°ΡΡ Π΄ΠΎ 5-10% ΠΎΡ Π²ΡΠ΅Ρ
ΡΠ°Π΄ΠΈΠΊΠ°Π»ΡΠ½ΡΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ